Overdose/Toxicities

Categories:

  • General Side Effects
    • Alpha-1 Antagonism (Norepinephrine)
      • Significant orthostatic hypotension/tachycardia
      • MC: Risperidone/Paliperidone, Clozapine, Thioridazine, Trazodone
    • Dopamine receptor antagonist
      • Metoclopramide
        • For nausea and vomiting, may have EPS
    • Histamine Antagonism (Histamine)
      • Sedation, appetite stimulation, weight gain
      • MC: Quetiapine (most sedating), Olanzapine (weight), Clozapine (weight), Thioridazine
    • Muscarinic Antagonism (Acetylcholine)
      • Anticholinergic – Delirium, fever, tachycardia, flushing, dry mucus membranes, constipation, Confusion and hallucinations
      • MC: Olanzapine, Clozapine, Thioridazine, Chlorpromazine
    • Side Effect Monitoring
      • EKG
        • Amitriptyline/TCAs
      • CBC
        • Clozapine (Agranulocytosis) weekly but not carbamazepine
      • Plasma levels
        • Lithium, valproate
      • Falls
        • TCAs and Benzos
      • Glucose
        • Clozapine after 6 months
      • Dextromethorphan (cough syrup)
        • Dissociative symptoms and hallucinations
        • Add Quetiapine to treat Pseudobulbar Affect

| Antipsychotic Extrapyramidal Effects – “ADAPT” | Pharmacotherapy | | — | — | | Acute Dystonia** (4 hours)** |

  • Sudden, sustained contraction of neck, mouth, tongue and eye muscles |
  • Benztropine
  • Diphenhydramine | | Akathisia** (Days to weeks)** |
  • Subjective inner restlessness, inability to sit still, wanting to walk off
  • Dose dependent |
  • Benzodiazepine (Lorazepam)
  • Low-Dose BB (Propranolol)
  • Benztropine | | Parkinsonism** (Weeks to months)** |
  • Gradual-onset tremor, rigidity and bradykinesia |
  • Benztropine≥
  • Amantadine
  • Trihexyphenidyl | | Tardive dyskinesia** (4 months)** |
  • Gradual onset after prolonged therapy (≥6m): dyskinesia of mouth, face, trunk, extremities |
  • Valbenazine
  • Deutetrabenazine
  • Switch to Clozapine or Quetiapine |

  • Acetaminophen Overdose
    • Gastroenteritis (non-specific) within hours, hepatoxicity within 1-2 days
      • Leading cause of hepatic failure in US
    • Treatment
      • Activated Charcoal and N-Acetylcysteine
      • Liver Transplant
  • Alcohol Intoxication
    • Slurred speech, incoordination, unsteady gait, attention/memory impairment, stupor, nystagmus
  • Alcohol/Methanol Overdose
    • Anion Gap Metabolic Acidosis
    • Fomepizole
      • Inhibits alcohol dehydrogenase
  • Alcohol Ketoacidosis
    • Slurred speech, unsteady gait, altered mentation
    • High Osmolar gap
    • Increased anion gap
    • Metabolic acidosis due to ketosis
  • Alcohol Withdrawal
    • Symptoms
      • Tachycardia, diaphoresis, anxiety, hallucinations, Seizures
        • Macrocytic anemia
      • Mild (6-24h) – anxiety, insomnia, tremors, diaphoresis, palpitations, GI upset, intact orientation
      • Seizures (12-48h) – single or multiple generalized tonic, clonic
      • Alcoholic hallucinosis (12-24h) – visual, auditory, or tactile; intact orientation
      • Delirium Tremens (48-96h) – unstable vitals, hallucinations, confusion
    • Withdrawal Prophylaxis
      • Chlordiazepoxide, Diazepam (medium-acting)
    • Treatment
      • IV Lorazepam ≥ Chlordiazepoxide
        • Especially in Liver disease
      • IVF, Thiamine, Folate
        • Thiamine prior to glucose
  • Anticholinergic Poisoning
    • Treatment
      • Physostigmine (cholinesterase inhibitors)
  • Arsenic Poisoning
    • Mechanism
      • Binds to sulfhydryl groups
      • Disrupts cellular respiration and gluconeogenesis
    • Sources
      • Pesticides, insecticides
      • Contaminated water, often from wells
      • Pressure-treated wood
      • Miners, smelters
    • Clinical
      • Acute: Garlic breath, vomiting, watery diarrhea, QTc prolongation
        • Dehydration secondary to vomiting and diarrhea
        • Seizure, delirium, coma, torsades de pointes
        • Acute tubular necrosis
        • Painful paresthesia, ascending weakness
      • Chronic: Pigmentation, hyperkeratosis, stocking-glove neuropathy
        • Cancer: Skin, bladder, kidney, and/or lung
      • Mees Lines (Leukonychia striata) on the nails (hypo/hyperpigmented)
    • Diagnosis: Elevated urine Arsenic Levels
    • Treatment
      • IM Dimercaprol (British anti-Lewisite)
      • DMSA (meso-2,3-dimercaptosuccinic acid, Succimer)
  • Barbiturate Overdose
    • Phenobarbital
    • Weak Acids
    • Treatment
      • Secure airway
      • Enhance elimination with Sodium Bicarbonate
        • Alkalinization of the urine
  • Benzodiazepine Overdose
    • Only Benzos = CNS depression with normal vitals
      • Altered LOC, ataxia, slurred speech
    • Benzos + Alcohol = CNS depression with abnormal vitals
      • Alcohol will cause bradycardia, hypotension, respiratory depression, hyporeflexia
    • Treatment
      • RR Normal (12-20)
        • Supportive Treatment
      • Emesis, Lavage, Charcoal
      • 1 Time Acute Overdose
        • Flumazenil
          • Avoid Flumazenil if chronic benzo user
          • Partial agonist, may precipitate withdrawal/seizures
          • Fixes CNS depression, less effective for respiratory
          • SE: Re-sedation, hypotension, hypertension, seizures in long term users, arrhythmias, angina
  • Beta Blocker Overdose
    • Bradycardia, AV block, and diffuse wheezing in a CAD patient
    • Drowsiness, fatigue, depression, Bradycardia, Torsade de points, worsening HF, hypertriglyceridemia, bronchoconstriction, ED, Weight gain
    • Treatment
      • Hypotension: IV Glucagon
      • Atropine, IV fluids
  • Carbon Monoxide Poisoning
    • Treatment
      • 100% O2
      • Hyperbaric Oxygen if CO is ≥25-40%
        • Lower if pregnant
  • Cocaine Toxicity
    • Inhibits norepinephrine reuptake into the sympathetic neuron (potentiating sympathomimetic actions)
      • Alpha and beta receptor stimulation results in coronary vasoconstriction and increased HR, Systemic BP, and Myocardial O2 demand
      • Enhances thrombus formation by promoting platelet activation and aggregation
    • Age <30 w/o FH, severe or malignant hypertension, resistant hypertension, sudden rise in BP
    • Sympathetic hyperactivity
    • Symptoms
      • Personality/mood changes, sleep loss, weight loss, financial difficulties
      • Chest pain, epistaxis, rhinitis, headaches
        • Cocaine-related Chest Pain (CRCP)
          • Can occur due to non-cardiac causes (hemorrhagic alveolitis, pneumothorax)
      • Hypertension, tachycardia, dilated pupils, psychomotor agitation, tremors
    • Complications
      • Seizures, Acute MI, Aortic Dissection, Intracranial hemorrhage
    • Diagnosis: Urine Drug Screen
    • Treatment of NSTEMI/Chest Pain:
      • Benzodiazepines for BP and Anxiety and O2 (lorazepam, diazepam)
        • Reduce sympathetic outflow (alleviate tachycardia, hypertension)
        • +/- Phentolamine if above doesn’t work
      • Aspirin
      • Nitroglycerin and CCBs for pain
      • Beta blockers are contraindicated
        • Would worsen coronary vasoconstriction (unopposed alpha-adrenergic stimulation)
      • No fibrinolytics
      • +/- Immediate Cardiac Catheterization
  • Cyanide Accumulation and Cyanide Toxicity
    • Cyanide is a potent inhibitor of cytochrome oxidase-a3 in the mitochondrial ETC
      • Inhibits cellular respiration
    • RF: Smoke inhalation (Mc toxicity in house fires)

      • Up to 90% of pts in house fires, only 35% have CO poisoning
      • Sodium Nitroprusside for hypertensive emergency
        • Prolonged use can lead to toxicity
        • More common in patients with renal insufficiency, signs of CHF
        • Onset is ~14-24 hours
    • Symptoms
      • Skin: Flushing before cyanosis
      • CNS: HA, AMS, seizures, coma, confusion, agitation
      • CV: Arrhythmias
      • Resp: Tachypnea followed by respiratory depression, Pulmonary edema
        • BP instability
      • GI: Pain, nausea, vomiting
        • “Almond like” odor to the breath
      • Renal: Metabolic acidosis (lactic acidosis), Renal failure
        • Bright red venous blood (elevated ventral venous oxyhemoglobin saturation
    • Treatment
      • Decontamination
        • Dermal
          • Remove clothing
        • Ingestion
          • Activated charcoal
        • Antidotes
          • 1) Hydroxocobalamin
            • Removes cyanide from mitochondrial respiratory system
          • 2) Sodium Thiosulphate
            • Slower onset, can’t be given with #1 or through the same catheter
          • 3) Sodium Nitrite
            • Only if ingested
            • Can’t be used in house fire victims due to synergistic effect with CO
      • Respiratory
        • No mouth-to-mouth resuscitation
        • Use supplemental O2/intubation
  • Digitalis Toxicity
    • Blocks na/k ATPase in myocardial cells
      • Leading to influx of calcium, increased contractility, increased SV
      • Prolongs refractory period reducing ventricular rate
    • Features
      • Characteristic ST depression with concave-up morphology “hockey stick”
      • AKI w/hyperkalemia and increased creatinine
      • Pain, nausea, vomiting
      • Confusion
      • Yellow halos around light, scotomas, blindness
  • Ethylene Glycol Ingestion
    • Symptoms
      • Flank Pain, hematuria, oliguria, cranial nerve palsies, tetany
    • Labs
      • High Osmolar gap
      • Increased anion gap
      • Metabolic acidosis
      • Calcium oxalate crystals in the urine
    • Treatment
      • Fomepizole or Ethanol
  • Heparin
    • Treatment
      • Protamine
  • Isopropyl Alcohol Ingestion
    • CNS depression, deconjugate gaze, absent ciliary reflex
    • High Osmolar gap
    • No Increased Anion Gap
    • No Metabolic acidosis
    • Treatment
      • Supportive Care
  • Malignant Hypertension (Hypertensive Crisis)
    • Binds to RYR1R causing CA2+ release.
      • MAOI + tyramine or stimulant
        • Prevents breakdown of tyramine in gut
        • Enhances peripheral NE effects increasing BP
    • Symptoms
      • Headache following a meal (tyramine)
      • Hypertension, sweating, HA, vomiting
      • Sympathomimetic effect (hypertension)
    • Labs
      • Increased BUN
    • Complications: Stroke, intracranial bleeding, death, rhabdomyolysis
    • Treatment
      • Stop agent
      • IV phentolamine
      • Dantrolene
      • Nifedipine can be helpful
    • Thyroxine (T4) is treated with IV thyroxine for myxedema
      • Coma required more
  • Methanol Ingestion
    • Visual Blurring, central scotomata, afferent pupillary defect, altered mentation, epigastric pain, hyperemic optic disc
    • High Osmolar gap
    • Increased anion gap
    • Metabolic acidosis
    • Treatment
      • Fomepizole (inhibits the alcohol dehydrogenase that converts methanol to formaldehyde)
      • Ethanol
  • Methemoglobinemia
    • Formed by the oxidation of ferrous to ferric iron in hemoglobin
    • Left shirt in the O2 curve because ferric iron cannot bind oxygen and this o2 binds tighter to ferrous iron in hemoglobin
    • Functional anemia
    • Causes: Dapsone, nitrates, topical/local anesthetics
    • Treatment
      • Methylene Blue
  • Neuroleptic Malignant Syndrome (NMS)
    • Antagonism of Dopamine (D2) receptors in the nigrostriatal pathway
      • Can occur with every class of antipsychotics
    • Symptoms
      • Slow onset, clouding of consciousness (over 1-3 days w/delirium being the 1st symptom)
      • Fever ≥104F, confusion, delirium or catatonia
      • Muscle rigidity (Lead-pipe), General muscle rigidity
      • Autonomic instability (Tachypnea, hypertension, tachycardia, dysrhythmia)
      • Abnormal vitals, sweating, mydriasis
    • Labs
      • Increased CPK, LFTs, WBCs
      • Myoglobin in urine
    • Treatment
      • Stop antipsychotics or restart dopamine agents
      • Antipsychotic meds
      • May have increases Creatine Kinase and WBCs
      • IV fluids, supportive care; ICU
      • Benzodiazepines
      • Dantrolene (skeletal muscle relaxant) or bromocriptine (dopamine agonist), amantadine (dopamine agonist) if refractory
  • Opioids
    • Treatment
      • Buprenorphine
        • Partial mu agonist, kappa antagonist
        • Treats withdrawal and chronic pain
        • Combined with naloxone (blocks receptor)
      • Naltrexone
        • Treats dependence, not withdrawal
      • Methadone
        • Treats withdrawl
  • Organophosphate Toxicity
    • Excessive salivation, miosis, lacrimation, diarrhea, emesis, urination, bronchospasm
    • Bradycardia, heart block, prolonged QTc
    • Treatment
      • Pralidoxime
        • Reverses muscle paralysis (nicotinic effects)
      • Atropine
  • Phencyclidine (PCP) Overdose
    • NMDA and Ach Antagonism
      • Particularly in the hippocampus and limbic system
    • Dopamine, norepinephrine, and serotonin receptor activation
    • Sigma receptor complex activation causing psychotic and anticholinergic effects
    • Lasts <8 hours
    • PCP withdrawal
      • Depression
    • Ketamine is shorter acting
    • Vertical or horizontal nystagmus, ataxia, violent behavior, hyperthermia, disorientation, delusions, muscle rigidity
    • Treatment
      • Psychomotor Agitation: Parenteral Benzodiazepines (lorazepam, diazepam) ≥ Haloperidol unless seizure disorder is present
        • B52 – Haloperidol, diphenhydramine, and benzodiazepine
  • Phenytoin Toxicity
    • Vertical Nystagmus
      • Cerebellar-vestibular system affected
      • Sedation, hypotension, arrhythmias, GI disturbances
      • Gingival hyperplasia and hirsutism if long-term use
    • 2nd line anticonvulsant (after lorazepam) in treating status epilepticus
    • Decreases repetitive firing of neuronal action potentials by slowing the rate of recovery of voltage gated sodium channels from inactivation
    • SE: SJS
  • Salicylate Poisoning
    • Treatment
      • Gastric Lavage, Activated charcoal, alkalinization of the urine, diuresis, dialysis
  • Serotonin Discontinuation Syndrome
    • RF: SSRIs with short half-life and no active metabolites
      • MC with short half-life SSRIs (paroxetine ≥ venlafaxine)
    • Onset within 3 days of discontinuation, resolution within 1-2 weeks
      • Fatigue, insomnia, myalgias from abrupt discontinuation in 20%
      • Headaches, anxiety, agitation
      • “Weird” sensations along arms and legs, “electric-shock-like” sensations in head/neck, “rushing” sensations in the head
      • Vertigo, tremor, ataxia
    • Treatment
      • Restart drug and taper gradually over several weeks (6-8 weeks)
      • If persistent, switch to Fluoxetine
  • Serotonin Syndrome (SS)
    • General
      • Over stimulation of 5-HT receptors in the central grey nuclei and the medulla
        • MC with stopping sertraline and fluvoxamine
        • Fluoxetine has a long half-life, must be quit 5 weeks prior to MAOI, but doesn’t need to be tapered
          • Tramadol (Ultram)
          • Serotonergic analgesic + SSRIs
    • Symptoms
      • Activity (hyperactivity, hyperreflexia, hypertonia, tremor, seizure)
        • Myoclonus, Lower extremity rigidity, tremor
      • Autonomic (hyperthermia, diaphoresis, diarrhea, mydriasis)
        • Flushing, Tachycardia, hypertension
      • Agitation (Need AMS)
        • Anxiety, confusion, hypomania, coma
      • Headaches, N/V/D, dizziness and fatigue when suddenly stopping
    • Exam
      • Hyperreflexia and myoclonus
      • Diaphoresis, hypertension, tachycardia
      • Fever/Hyperthermia, cardiovascular collapse
    • Labs
      • No CPK or liver enzyme changes
    • Treatment
      • Discontinue serotonergic meds, supportive, benzodiazepines, cyproheptadine
      • Cyclobenzaprine
      • Cyproheptadine (H1 receptor antagonist)
        • Weakly cholinergic hypotension
  • Steroids
    • Glucocorticoids/Prednisone (Asthma/Lupus)
    • Delusions/hallucinations. Alert and cognitively intact
    • Anxiety, depression, psychosis, mania rarely
    • Usually occur during the first week but may occur at any time
  • Tardive Dyskinesia
    • 98% get worse with acute cessation of antipsychotic
      • D2 receptor upregulation and super sensitivity
      • Chronic blockade of dopamine receptors causes this
    • Treatment
      • Switch from risperidone to clozapine (atypical antipsychotic)
      • VMAT2 Inhibitors
        • Blocks presynaptic dopamine release
          • May cause depletion of dopamine in synaptic cleft causing depression
        • Deutetrabenazine (Austedo)
          • TD and Huntington’s
        • Valbenazine (Ingrezza)
        • Reserpine
  • TCA (Tricarboxylic Acid) Overdose
    • Features
      • Antihistamine Effects
        • Drowsiness, delirium, coma, seizures, respiratory depression
      • Anticholinergic Effects
        • Dry mouth, blurred vision, mydriasis, urinary retention
        • Flushing, hyperthermia
      • Hypotension, sinus tachycardia, prolonged PR/QRS/QT, Arrythmias
        • QRS ≥ 100ms is MC EKG abnormality
      • 1500mg for ≥4 hours = death
    • Treatment
      • O2 and intubation, EKG monitoring
      • IV fluids
      • Activated charcoal if within 2 hours of ingestion (unless ileus present)
      • Seizures: Benzodiazepines
      • QRS ≥100: IV Sodium Bicarbonate
        • Therapy for QRS widening or ventricular arrythmia
        • QRS ≥ 100msec is associated with increased risk of arrhythmias and/or seizures
        • Cardioprotective and helps metabolic acidosis
  • Theophylline Toxicity
    • Toxic form reduced clearance or decreased metabolism in the liver
    • CNS Stimulation (headache, insomnia, seizures), GI (Nausea, vomiting), and cardiac toxicity (arrhythmia)
    • Measure theophylline levels
  • tPA
    • Treatment
      • Aminocaproic Acid
  • Warfarin
    • Treatment
      • Vitamin K, FFP

results matching ""

    No results matching ""